GENE ONLINE|News &
Opinion
Blog

2022-04-21|

AACR 2022: Stand Up to Cancer, Standing up to Treatment

by Eduardo Longoria
Share To
At the AACR 2022 Annual Meeting, a session titled “Optimizing Cell-based Therapies for Clinical Impact,’ an open scientific session, was hosted by Raymond DuBois, the Dean of the College of Medicine at the Medical University of South Carolina. Researchers discussed advancements in optimizing cell-based therapies for various cancers. The theme of the research presented by the 4 groups was the increasing specificity with which therapies are able to target cancer cells and the current problems with broad solutions such as chemotherapy and radiation. 

It's free! Log in now to read

LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top